Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,144.20
-42.50 (-3.58%)
Feb 18, 2026, 10:40 AM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 689.24 billion as of February 17, 2026. Its market cap has increased by 2.64% in one year.
Market Cap
689.24B
Enterprise Value
678.19B
Revenue
331.82B
Ranking
n/a
PE Ratio
19.77
Stock Price
1,144.20
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 689.24B, an increase of 7,077.11%. That is a compound annual growth rate of 19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 689.24B | 0.31% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.64T |
| Cipla | 1.08T |
| Zydus Lifesciences | 910.34B |
| Mankind Pharma | 850.58B |
| Alkem Laboratories | 645.95B |
| Glenmark Pharmaceuticals | 563.72B |
| Laurus Labs | 545.58B |
| Ipca Laboratories | 376.85B |